Jefferies Lifts Target on Abbott Labs (ABT) After Carving Out AbbVie

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. INTU
2. DKS
3. NVDA
4. META
5. ZM
6. SMTC
7. SPY
8. JAZZ
9. NCNO
10. BOX

September 19, 2012 8:26 AM EDT
Get Alerts ABT Hot Sheet
Price: $114.10 -1.75%

Rating Summary:
    26 Buy, 9 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 4 | Down: 20 | New: 18
Join SI Premium – FREE
Jefferies boosted its price target on Buy-rated Abbott Labs (NYSE: ABT) from $75 to $85 after carving out split-off AbbVie in their model.

"We now value AbbVie at $55 per share with the remaining Abbott business (DMP) valued at $30 per share, making our new PT $85," the analyst said.

"Abbott remains our top pick through 2012 and we see a strong set of newsflow and valuation drivers over the next 6 months."

FY12 EPS was raised from $5.71 to $5.83 and FY13 from $6.30 to $6.36.

For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.

Shares of Abbott Labs closed at $68.91 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Jefferies & Co